BOAN BIOTECH 06955·

Gross margin 67.11%--68.65%1.54%66.16%2.49%74.71%8.55%71.66%3.05% Net margin -142.04%---64.30%77.74%-19.31%44.98%10.08%29.39%0.91%9.17% ROE -14.53%---23.39%8.86%-9.04%14.34%4.45%13.50%0.26%4.19% ROA -10.70%---15.06%4.36%-5.14%9.92%2.57%7.70%0.17%2.39% Revenue growth ----225.11%--19.80%205.31%17.50%2.30%8.06%9.45% Attributable profit growth -----47.17%--64.02%111.19%161.31%97.29%-90.24%251.55% Debt-to-assets 26.34%--35.60%9.26%43.19%7.59%42.34%0.85%33.59%8.75% Current ratio 3.61--1.801.811.090.701.470.382.330.85 Operating cash flow / net profit 1.09--0.610.480.160.45-1.611.779.0810.69 Operating cash flow / revenue -155.18%---39.12%116.06%-3.00%36.12%-16.24%13.23%8.27%24.51%

Gross margin 71.83%--62.66%9.17% Net margin 5.21%---35.63%40.84% Revenue growth -----40.77%-- Attributable profit growth -----504.65%-- Current ratio ----1.74--

Revenue 158.70M--515.96M225.11%618.13M19.80%726.32M17.50%784.82M8.06% Other income and gains 13.37M--24.35M82.18%27.65M13.58%45.09M63.04%15.54M65.52% Gross profit 106.51M--354.23M232.57%408.97M15.45%542.65M32.69%562.44M3.65% Selling and distribution expenses 54.05M--214.09M296.10%256.53M19.83%285.84M11.43%340.90M19.26% Administrative expenses 42.16M--82.33M95.27%51.69M37.22%46.46M10.11%41.19M11.35% Net finance costs 11.60M--13.41M15.59%14.09M5.07%32.65M131.78%38.66M18.40% Operating profit -213.82M---318.34M48.88%-105.29M66.93%105.84M200.52%45.80M56.73% Profit before tax -225.42M---331.75M47.17%-119.38M64.02%73.19M161.31%7.14M90.24% Net profit -225.42M---331.75M47.17%-119.38M64.02%73.19M161.31%7.14M90.24% Net profit attributable to owners -225.42M---331.75M47.17%-119.38M64.02%73.19M161.31%7.14M90.24%

Revenue 393.41M--233.00M40.77% Other income and gains 2.58M--7.38M185.80% Cost of sales 110.83M--87.00M21.49% Gross profit 282.58M--146.00M48.34% Selling and distribution expenses 159.79M--107.11M32.97% Administrative expenses 23.18M--15.46M33.29% Net finance costs 19.53M--21.69M11.04% Income tax 0--0-- Profit before tax 20.51M---83.01M504.65% Net profit 20.51M---83.01M504.65% Net profit attributable to owners 20.51M---83.01M504.65%

Cash and cash equivalents 613.56M--233.50M61.94%201.85M13.55%198.87M1.48%1.13B468.42% Trade and bills receivables 107.27M--212.12M97.75%276.19M30.20%453.60M64.23%671.27M47.99% Inventories 98.84M--143.63M45.32%165.29M15.08%168.25M1.79%129.96M22.76% Total current assets 939.85M--846.67M9.91%713.01M15.79%956.28M34.12%2.01B110.54% Total assets 2.11B--2.20B4.55%2.32B5.49%2.85B22.72%4.13B44.69% Total current liabilities 260.48M--471.67M81.08%653.35M38.52%648.68M0.71%864.65M33.29% Total liabilities 554.92M--784.18M41.32%1.00B27.97%1.21B20.30%1.39B14.79% Equity attributable to owners 1.55B--1.42B8.59%1.32B6.95%1.64B24.56%2.74B66.66% Total equity 1.55B--1.42B8.59%1.32B6.95%1.64B24.56%2.74B66.66%

Cash and cash equivalents ----1.11B-- Trade and bills receivables ----571.74M-- Inventories ----174.36M-- Total current assets ----1.92B-- Total assets ----2.95B-- Total current liabilities ----1.11B-- Equity attributable to owners ----2.66B-- Total equity ----2.66B--

Net cash from operating activities -246.28M---201.84M18.04%-18.57M90.80%-117.94M535.16%64.89M155.02% Net cash from investing activities -432.30M---100.68M76.71%-293.57M191.58%-362.89M23.61%-274.05M24.48% Net cash from financing activities 1.21B---127.00K100.01%283.09M223002.36%477.83M68.79%1.14B138.77% Net change in cash 533.15M---302.65M156.77%-29.05M90.40%-3.00M89.68%931.75M31189.39%